Westfield Capital Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-1,153,163
| Closed | -$37M | – | 301 |
|
|
2016
Q4 | $37M | Buy |
1,153,163
+22,735
| +2% | +$730K | 0.32% | 107 |
|
|
2016
Q3 | $56.5M | Sell |
1,130,428
-22,948
| -2% | -$1.15M | 0.46% | 78 |
|
|
2016
Q2 | $48.9M | Buy |
1,153,376
+120,432
| +12% | +$5.11M | 0.4% | 87 |
|
|
2016
Q1 | $68M | Buy |
1,032,944
+110,730
| +12% | +$7.29M | 0.52% | 64 |
|
|
2015
Q4 | $57.3M | Buy |
922,214
+94,595
| +11% | +$5.88M | 0.39% | 88 |
|
|
2015
Q3 | $55.4M | Buy |
827,619
+207,159
| +33% | +$13.9M | 0.39% | 88 |
|
|
2015
Q2 | $60.4M | Buy |
620,460
+251,418
| +68% | +$24.5M | 0.37% | 95 |
|
|
2015
Q1 | $34.5M | Buy |
+369,042
| New | +$34.5M | 0.2% | 144 |
|
|
2013
Q4 | – | Sell |
-179,194
| Closed | -$5.34M | – | 368 |
|
|
2013
Q3 | $5.34M | Sell |
179,194
-10,420
| -5% | -$311K | 0.03% | 248 |
|
|
2013
Q2 | $10.1M | Buy |
+189,614
| New | +$10.1M | 0.07% | 240 |
|